Hertfordshire and West Essex ICB
Prescribing, Policies and Pathways
Prescribing, Policies and Pathways
The last day of operation for Hertfordshire and West Essex ICB was 31 March 2026. The information on this website has not been updated since 31 March 2026. The legacy policies, prescribing recommendations and pathways can be accessed on this website. Find out more
or
| Medicine / Guideline | Indication | RAG rating | Document type | Place |
|---|---|---|---|---|
| Acne vulgaris | Acne vulgaris | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Amikacin | Cystic fibrosis (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Antibiotic toolkit TARGET | Antimicrobial stewardship | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Antimicrobial Q&A ECF 2025-26 | Antibiotics - ECF FAQs | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Azithromycin in adults with COPD | Azithromycin in adults with COPD - prophylactic | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Aztreonam lysine | Cystic fibrosis chronic pseudomonas aeruginosa (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Bezlotoxumab | Clostridium difficile | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Bictegravir | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Blepharitis | Blepharitis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Bronchiectasis | Bronchiectasis - acute exacerbation of (non-cystic fibrosis) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Cabotegravir | Preventing HIV-1 | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Candidiasis | Candidiasis - oral | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Candidiasis | Candidiasis - vaginal | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Casirivimab plus imdevimab | COVID-19 | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Cefiderocol | Drug-resistant gram-negative bacterial infections severe (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Ceftazidime with avibactam | Drug-resistant gram-negative bacterial infections severe (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Cellulitis and erysipelas | Cellulitis and erysipelas | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Chlamydia trachomatis / urethritis | Chlamydia trachomatis / urethritis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Chronic Fatigue Syndrome/Myalgic Encephalitis (CFS & ME) Inpatient Treatment | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Clostridioides difficile infection | Clostridioides difficile infection | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Cold sores | Cold sores | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Colistimethate sodium (Colobreathe) | Cystic fibrosis (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Community LRTI Pneumonia Intravenous Antibiotic pathway for Housebound Care Home patients Pathway | n/a | Clinical pathways | East and North Hertfordshire | |
| COPD | COPD - acute exacerbation of | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Cough | Cough - acute | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| COVID Virtual Ward | n/a | Patient information | East and North Hertfordshire | |
| COVID-19 Oximetry at Home | n/a | Patient information | East and North Hertfordshire | |
| COVID-19 Respiratory Disease Update | n/a | Patient information | Hertfordshire and West Essex ICB | |
| COVID-19 treatments: Information for clinicians | COVID-19 | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Darunavir | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Dental abscess | Dental abscess | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Dermatophyte infection | Dermatophyte infection: skin | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Dermatophyte infection | Dermatophyte infection: nail | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Diabetic foot infection | Diabetic foot infection | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Diarrhoea | Diarrhoea infectious | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Diarrhoea | Diarrhoea - Traveller’s | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Diverticulitis | Diverticulitis - acute | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Dolutegravir | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Eczema (bacterial infection) | Eczema (bacterial infection) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Efavirenz | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Elbasvir | Hepatitis C (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Emtricitabine | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Entecavir | Hepatitis B (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Epididymitis | Epididymitis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Ethambutol | Tuberculosis (NHSE) | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Genital herpes | Genital herpes | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Gingivitis | Gingivitis - simple - mucosal ulceration and inflammation | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Gingivitis | Gingivitis - acute necrotising ulcerative | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Gonorrhoea | Gonorrhoea | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Grazoprevir | Hepatitis C (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Helicobacter pylori | Helicobacter pylori | Green | Decision document | Hertfordshire and West Essex ICB |
| Herpes zoster / shingles | Herpes zoster / shingles | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| how to access TARGET resource guide | Guide | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Human and animal bites | Human and animal bites | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Impetigo | Impetigo | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Infections in Primary Care | Infections | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Influenza | Influenza | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Insect bites and stings | Insect bites and stings | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Isavuconazole | Antifungal (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Isoniazid | Tuberculosis (NHSE) | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Lamivudine | Hepatitis B (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Leg ulcer infection | Leg ulcer infection | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Letermovir | Cytomegalovirus (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Linezolid | Antibacterial | Red | n/a | Hertfordshire and West Essex ICB |
| Long COVID | n/a | Decision document | Hertfordshire and West Essex ICB | |
| Mastitis | Mastitis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Meningitis | Meningitis - prevention of secondary case | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Meningococcal disease | Meningococcal disease - suspected | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Methenamine | Recurrent adult | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Minocycline | Acne | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Molnupiravir | COVID-19 (CMDU only) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Nevirapine | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Nirmatrelvir plus ritonavir | COVID-19 (CMDU only) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Nitazoxanide | Viral hepatitis (B&C) and respiratory syncytial virus (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Nitrofurantoin oral solution to capsules switch Patient Letter | urinary tract infection | n/a | Patient information | Hertfordshire and West Essex ICB |
| Otigo (anaesthetic and analgesic) | Otitis media | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Otitis externa | Otitis externa - acute | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Otitis media | Otitis media - acute | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Panton-Valentine leukocidin (PVL) | Panton-Valentine leukocidin (PVL) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Peginterferon and ropeginterferon | Hepatitis and Multiple sclerosis (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Pelvic inflammatory disease (PID) | Pelvic inflammatory disease (PID) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Pericoronitis | Pericoronitis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Pneumonia | Pneumonia - community acquired | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Pneumonia | Pneumonia - hospital acquired | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Posaconazole | Fungal infections (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Prostatitis | Prostatitis - acute | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Pyelonephritis | Pyelonephritis - acute upper urinary tract | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Pyrazinamide | Tuberculosis (NHSE) | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Raltegravir | HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Remdesivir | COVID‑19 | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Rifampicin | Tuberculosis (NHSE) | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Ritonavir | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Scabies | Scabies | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Scarlet fever (GAS) | Scarlet fever (GAS) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Sexual Health Pathway | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Silver dressings | Wound Care | n/a | Position statement | Hertfordshire and West Essex ICB |
| Sinusitis | Sinusitis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Sore throat | Sore throat - acute | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| STI screening | STI screening | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Tenofovir | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Threadworm | Threadworm | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Tick bites (Lyme disease) | Tick bites (Lyme disease) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Tixagevimab plus cilgavimab | COVID‑19 | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Tixagevimab plus cilgavimab | COVID-19 | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Tobramycin (TOBI Podhaler) | Cystic fibrosis (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Tocilizumab | COVID-19 | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Trichomoniasis | Trichomoniasis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Urinary tract infection | Urinary tract infection - lower | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Urinary tract infection | Urinary tract infection - catheter associated | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Urinary tract infection (UTI) | Urinary tract infection | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Urinary Tract Infections (UTI) | Recurrent - adult | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Vaginosis | Vaginosis - bacterial | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Varicella zoster / chickenpox | Varicella zoster / chickenpox | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Voriconazole | Chronic pulmonary aspergillosis and fungal infections (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |